Neurodevelopmental Disorders | CHOP Research Institute
 

Neurodevelopmental Disorders

Dr. Festa works to understand the molecular mechanisms underpinning normal neurodevelopment with a specific focus on white matter. She also focuses on discovering new therapeutic targets to restore or prevent white matter injury across a number of different pediatric neurologic conditions.

E-mail:
festal1 [at] chop.edu
Published on
Nov 5, 2025
Targeting the mitochondria improved blood-brain barrier function and cognition in a preclinical model of the genetic disorder.

The Qian Lab studies human cerebral cortex development and disease using brain organoids, spatial omics, and genetics to uncover mechanisms of normal development and neurodevelopmental disorders, with the goal of enabling human-specific therapeutic insights.

Dr. Xuyu Qian investigates the development and diseases of the human cerebral cortex to elucidate the underpinnings of normal brain development and neurodevelopmental disorders. His research integrates spatial omics, brain organoids, and genetics to overcome limitations of traditional models.

E-mail:
qianx [at] chop.edu
Published on
Nov 22, 2024
CHOP researchers are developing a tool to illuminate brain activity in children with severe neurodevelopmental disorders, who are often excluded from research.
Published on
Oct 10, 2024
Meet our October Featured Research Trainee, Sabrina A. Santos De León to learn more about her work with neurodevelopmental disorder phenotypes.
Published on
Sep 16, 2024
CHOP’s new translational neuroscience center, BRIDGE, works to understand basic and translational mechanisms of neurodevelopmental disorders.

The Center for Brain Research in Development, Genetics and Engineering (BRIDGE) applies innovative technology and advanced model systems to understand basic mechanisms of brain development and advance the implementation of novel therapeutics.

The Cristancho Lab is interested in understanding the epigenetic mechanisms driving long-term neurodevelopmental disabilities from acquired prenatal and perinatal brain injury. Our goal is to develop novel therapies that can be used throughout the lifespan to improve outcomes for children.

Dr. Gandal investigates the genetic contributions to typical human brain development and neurodevelopmental and psychiatric disorders. His multidisciplinary research program integrates genetics with functional genomic profiling in the human brain, along with bioinformatics and computational biology.

E-mail:
gandalm [at] chop.edu